Abstract:Introduction Obesity in young adulthood is associated with various cardiovascular structural and functional changes, commonly used as markers of early subclinical cardiovascular disease. Whether these changes occur predominantly in relation to increased fat mass (FM) or are instead more closely related to simultaneous increases in underlying fat-free mass (FFM) that are known to occur in obesity, is incompletely understood. Purpose To investigate associations between both FM and FFM and a wide range of cardiac (left ventricular mass, LVM; end-diastolic volume, EDV; cardiac output, CO; stroke volume, SV), vascular (systolic blood pressure, SBP; diastolic blood pressure, DBP; mean arterial pressure, MAP; systemic vascular resistance, SVR) and autonomic (heart rate variability triangular index, HRVTI; baroreceptor reflex sensitivity, BRS) phenotypes commonly used to monitor the early evolution of subclinical CVD. Methods The study used data from extensive adipose and cardiovascular phenotyping of 408 healthy young adults (mean age 21 years) participating in a sub-study of the long-running ALSPAC birth cohort. We performed cross-sectional analysis using multiple imputation, multivariable linear regression and interaction testing to assess the association between both FM and FFM and cardiovascular phenotypes. Results Our study revealed that FFM resulted in a much greater increase in CO (difference in outcome per 1-SD difference in exposure β=0.58L/min, p<0.01, 95% CI=0.38, 0.77) than FM (β=0.20L/min, p=0.01, 95% CI=0.05, 0.36), following adjustment for both tissue types. FFM was also associated with an increase in LVM (β=19.1g, p<0.01, 95% CI=16.61, 21.58), EDV (β=22ml, p<0.01, 95% CI=18.18, 25.13) and SV (β=13ml, p<0.01, 95% CI=10.96, 15.75). FFM was also associated with improved autonomic and peripheral vascular function, including lower HR (β=-4bpm, p<0.01, 95% CI=-6.12, -1.95), higher HRVTI (β=2.1, p<0.01, 95% CI=0.72, 3.48) and lower SVR (β=-1.1, p<0.01, 95% CI=-2.12, -1.07), resulting in unchanged MAP despite elevations in CO. On the contrary, FM was not associated with LVM (β=-0.91g, p=0.35, 95% CI=-2.85, 1.02), and was associated with lower EDV (β=-4.62ml, p<0.01, 95% CI=-7.34, -1.88) and reduced autonomic function, as seen with HRVTI (β=-1.83, p<0.01, 95% CI=-3.02, -0.64) and BRS (β=-2.47, p=0.01, 95% CI=-4.27, -0.67). FM was also associated with increased HR (β=3.26bpm, p<0.01, 95% CI=1.57, 4.94) and increased SBP (β=2.14mmHg, p<0.01, 95% CI=1.01, 3.27) DBP (β=2.68mmHg, p<0.01, 95% CI=1.60, 3.77), and MAP (β=2.34mmHg, p<0.01, 95% CI=1.34, 3.34). Conclusion In young adults, changes in surrogate clinical markers of cardiac, vascular, and autonomic function commonly attributed solely to increases in fat mass should be interpreted with caution as they may be associated with underlying changes in FFM. Future work should focus on longitudinal studies of this cohort to confirm remodelling patterns based on these clinical markers.

The various associations between whole /regional fat mass and trajectory of cardiometabolic diseases: a nonlinear multistate model

Roles of general and central adiposity in cardiometabolic multimorbidity: revisiting the obesity paradox using a multistate model

Truncal and Leg Fat Associations with Metabolic Risk Factors among Chinese Adults.

Visceral adiposity associated with incidence and development trajectory of cardiometabolic diseases: A prospective cohort study

Sex-specific associations between total and regional Fat-to-muscle Mass ratio and cardiometabolic risk: findings from the China National Health Survey

Mid-Arm Muscle Circumference and Triceps Skinfold Thickness Associated with Cardiometabolic Disease in Chinese Residents: A Prospective Cohort Study

Association of body fat distribution with all-cause and cardiovascular mortality in US adults: a secondary analysis using NHANES

Association of Body Mass Index with Risk of Cardiometabolic Disease, Multimorbidity and Mortality: a Multi-State Analysis Based on the Kailuan Cohort.

Total and regional fat-to-muscle mass ratio in relation to all-cause and cause-specific mortality in men and women

Associations of Regional Body Fat with Risk of Cardiovascular Disease and Mortality among Individuals with Type 2 Diabetes

Total and Regional Fat/Muscle Mass Ratio and Risks of Incident Cardiovascular Disease and Mortality

Observational and genetic associations of adiposity with cardiopulmonary multimorbidity: Linear and nonlinear Mendelian randomization analysis

Differential impacts of fat and muscle mass on cardiovascular and non‐cardiovascular mortality in individuals with type 2 diabetes

Lifestyle, cardiometabolic disease, and multimorbidity in a prospective Chinese study

Joint Association Between Body Fat and Its Distribution with All-Cause Mortality: A Data Linkage Cohort Study Based on NHANES (1988-2011).

The Association Between Fatigue and Cardiometabolic Diseases: Insights from the UK Biobank Study

Total and Regional Fat‐to‐muscle Mass Ratio and Risks of Incident All‐cause Dementia, Alzheimer's Disease, and Vascular Dementia

Association of Adiposity Indices with Cardiometabolic Multimorbidity among 101,973 Chinese Adults: a Cross-Sectional Study

Total and regional fat‐to‐muscle mass ratio measured by bioelectrical impedance and risk of incident type 2 diabetes

Genetically predicted body composition in relation to cardiometabolic traits: a Mendelian randomization study

Assessment of body composition in young adulthood and its associations to early changes in cardiovascular phenotypes: a cross-sectional study